CING Cingulate Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Mar 25, 2026 Processed 2mo ago SEC 9999999995-26-000923
IPO/offering going effective
Latest settled — T+20d
CING ▼ -11.64% at T+20d
NEUTRAL call ✗ call lost -11.64% · α vs SPY -19.50% · entry $6.36 → $5.62
Next anchor: T+60d in 12d
Currently $4.65 · -26.89% from $6.36 entry
Entry anchored
Mar 24, 03:59 PM ET
via Databento tick
T+1d
-1.26%
call -1.26% · α +0.51%
$6.28
settled 3mo ago
T+5d
-5.50%
call -5.50% · α -5.26%
$6.01
settled 2mo ago
T+20d
-11.64%
call -11.64% · α -19.50%
$5.62
settled 7w ago
T+60d
call — · α —
in 12d

Price Chart

Loading chart...

Executive Summary

Cingulate Inc.'s Form S-3 shelf registration has become effective as of March 24, 2026, allowing the company to issue unspecified securities from time to time. This creates a potential for future equity offerings, which may lead to dilution, though no immediate issuance has been announced.

Actionable Insight

Monitor for future prospectus supplements or 8-K filings that may announce actual securities sales under this shelf registration. Traders should be alert to potential near-term dilution if equity is issued.

Key Facts

  • Form S-3 shelf registration (File No. 333-292680) became effective on March 24, 2026.
  • The S-3 allows Cingulate Inc. to issue unspecified amounts of securities, including common stock, preferred stock, warrants, or debt, over time and under various conditions.
  • No securities were issued at effectiveness; this is a procedural step enabling future offerings.
  • The company operates in the pharmaceutical preparations sector (SIC 2834) and is incorporated in Delaware.

Financial Impact

Potential future dilution or capital raise of unspecified size; no immediate financial impact.

dilutionequitydebtcash

Risk Factors

  • Future equity issuance could lead to share dilution and downward pressure on stock price.
  • Market perception of a 'dilution overhang' may weigh on sentiment even without immediate offerings.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000923
Document: 9999999995-26-000923-index.html9999999995-26-000923
Document: 9999999995-26-000923.txt9999999995-26-000923
5 reports for CING
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CING — sortable, filterable
Type Now
Jun 8, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
$4.53 awaiting T+20awaiting T+20$4.65 (+2.65%)
Mar 25, 2026
10w ago
EFFECT
NEUTRAL ★ 4/10
$6.36 $5.62▼ −11.64%▼ −19.50%$4.65 (−26.89%)
Mar 23, 2026
11w ago
S-3/A
BEARISH ★ 3/10
$6.93 $5.86▲ +15.44%▲ +22.86%$4.65 (+32.90%)
Mar 18, 2026
11w ago
DEFA14A
NEUTRAL ★ 3/10
$7.51 $5.45▼ −27.43%▼ −35.05%$4.65 (−38.08%)
Mar 18, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$8.04 $5.26▼ −34.58%▼ −40.62%$4.65 (−42.16%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (10h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access